Democrat Senate Hopeful SHRUGS Off Long MRI Waits

Medical billing statement with stethoscope and blue calculator — Photo: everydayplus / Shutterstock

The fight over “waits versus debt” in U.S. health care is not a gaffe war; it is the central allocation problem any system must solve: will we ration care by time, by price, or some combination of both—and with what safeguards for people whose health or finances cannot absorb delay.

At a Glance

Abdul El‑Sayed’s blunt MRI remark crystallizes a real tradeoff: today’s system often offers speed to those who can pay, while his Medicare‑for‑All framing prioritizes protection from medical debt even if some waits persist.
The financial barrier he highlights is well documented: medical debt deters and delays needed care, even among the insured, and features heavily in debt collections data.
Opponents translate his framing into claims of longer waits, higher taxes, and lower quality; some financing analyses suggest middle‑class taxes would rise to fund universal coverage.
Neither camp has produced load‑bearing evidence on MRI wait impacts of his specific plan; the decisive variables are capacity, triage, and operations—not insurance labels alone.

What El‑Sayed actually argued—and what the quote does and does not prove

Circulating clips quote El‑Sayed saying a friend’s cousin faced a “long line for an MRI” and, “that sucks for them, but also that person has never had to worry about medical debt.” The line reads as callous out of context; read as policy shorthand, it draws a bright contrast between speed and financial exposure under today’s patchwork versus debt protection under a universal plan. The clip is anecdotal and lacks clinical detail—urgency, location, the actual interval, and whether the queue arose from public financing, private utilization management, or plain capacity constraints—so it does not establish that his plan would lengthen waits. It does establish his core prioritization: eliminate premiums, copays, and deductibles, even if some non‑urgent waits persist under stronger triage.

That prioritization is consistent with El‑Sayed’s written testimony describing his own insurance hurdles (a $3,200 deductible and a $4,600 out‑of‑pocket maximum) and summarizing research that medical debt leads people to delay or forgo care altogether. If you think of access as a chain, a queue at the scanner is one weak link; a $4,500 family deductible is another. He is choosing which link to reinforce first.

The other side’s case: waits, taxes, and quality—what’s asserted versus what’s evidenced

Critics translate El‑Sayed’s remark into a broader indictment: universal public coverage means longer queues, higher taxes, lower quality, and rationing. Some of this is straightforward framing—“government‑run” as a proxy for scarcity and control—rather than specific evidence about his plan’s operations. Claims that middle‑class taxes would likely rise to fund Medicare‑for‑All come from analyses arguing that taxes on the wealthy and businesses cover only a share of projected costs; that is a legitimate financing concern, even if total household health spending would fall for many families once premiums and cost‑sharing disappear. The jump from “more public financing” to “longer MRI waits,” however, is not a law of nature; it depends on capacity, payment rates, and queue management, which the available criticism does not quantify.

It is also worth separating methods from goals. Rationing happens now, but we disguise it as price: high deductibles, surprise bills, and network exclusions filter demand. Universal systems shift some rationing to time and triage. The quality question hinges on whether the system builds enough imaging capacity, protects urgent pathways, and continuously improves scheduling and throughput. Those are engineering and budgeting choices, not inevitable consequences of a single‑payer label.

What the evidence does say about queues and about debt

Comparative research shows waiting times for non‑emergency care are a recurring policy problem across systems; their magnitude varies with capital stock, staffing, demand, and operations, not with the insurance card alone. Within any system, delays can cascade: triage lag raises waits for both urgent and routine referrals, with disproportionate effects on routine cases—a reminder that managing the front door matters as much as adding machines. Conversely, targeted operational changes—fast tracks, priority beds, clear care pathways—can materially reduce waits without changing insurance design. These findings imply a simple truth: capacity and workflow are the levers.

On the financial side, the evidence is clearer. Medical debt is pervasive and distorting. Consumer credit data and health‑policy research find medical bills constitute a large share of collections, and once in debt, people skip doctor visits, tests, and medications; cost concerns delay care even among the insured. In his testimony, El‑Sayed cites survey findings that significant shares of indebted patients report being denied care or deferring treatment because of cost; while survey estimates vary by instrument and year, the direction of effect is consistent across sources. If policy is about reducing avoidable harm, preventing debt‑driven underuse belongs on the first page of the agenda.

Capacity, not slogans, decides MRI waits

Would a Medicare‑for‑All‑style plan inevitably lengthen MRI waits? The available record does not answer that. To predict wait times credibly, you need a model that marries demand (indications by age and disease burden), effective prices (out‑of‑pocket at the point of care), and supply (scanners per capita, operating hours, technologists, radiologists, maintenance downtime) to scheduling rules (urgent targets, cancer pathways, centralized lists). None of the circulating critiques supply such a model; nor do El‑Sayed’s materials quantify imaging capacity or wait‑time targets. In practice, universal systems that paired coverage expansion with capital and workforce investment have stabilized or reduced waits; systems that expanded coverage without adding throughput saw queues grow. The design choice is not whether to accept waits, but whether to finance and govern to keep them clinically acceptable.

This is where plan architecture matters. A defensible design would enshrine maximum‑wait guarantees by acuity (for example, next‑day for suspected spinal cord compression, one week for new focal neurologic deficit, two weeks for suspected cancer), fund extended scanner hours, deploy mobile MRI to under‑served regions, and centralize scheduling to match idle slots with demand. It would also measure and publish interval data—referral to triage, triage to scheduling, scheduling to scan—so bottlenecks are visible and fixable. None of that conflicts with eliminating premiums or deductibles.

Debt relief as proof of concept—and its limits

El‑Sayed points to local debt‑relief work as evidence of commitment to financial protection. Wayne County’s initiative retired tens of millions in medical debt for tens of thousands of residents over two years; the program fell far short of an earlier $700 million headline capacity, which critics fairly note as an implementation gap. The lesson is not that debt relief is misguided; it is that scale and delivery discipline matter. A national plan would need industrial‑strength purchasing, standardized eligibility, and near‑real‑time adjudication to prevent the debt from accruing in the first place.

Abdul El-Sayed doesn’t care that his government-run healthcare plan increases wait times for patients.

“I have a friend whose cousin…had to wait in a long line for an MRI and I say, ‘Well that sucks for them, but also that person has never had to worry about medical debt.’” pic.twitter.com/3Pp8R17LAU

— RNC Research (@RNCResearch) October 16, 2026

A cleaner way to frame the choice

The MRI soundbite tempts us to treat waiting as a moral verdict on universal coverage. That is backward. Every system rations; the question is whether we ration invisibly through price and paperwork, or visibly through triage and time, and whether we invest enough capacity to make those waits clinically safe. The evidence on debt’s harms is strong; the evidence tying a specific Medicare‑for‑All design to longer MRI waits is absent. The responsible path is to pair financial protection with explicit wait‑time standards, capacity investment, and operational excellence. If a plan cannot show, in numbers, how many scanners will run, for how many hours, staffed by whom, and monitored against what targets, it is not a health system—it is a slogan.